Peyman - Wikipedia. Gholam A. Peyman. Born. Shiraz, Iran. Residence. Phoenix, United States. Nationality. Iranian- American. Fields. Ophthalmology, Engineering. The website Assabile offers the Qur'an recited in Arabic for free by more than a hundred reciters. You can also download the full Quran for free in mp3 and pdf format. Institutions. Professor of Basic Medical Sciences at the University of Arizona, Phoenix & Optical Sciences at University of Arizona Tucson, Arizona. Emeritus Professor of Ophthalmology, Tulane University. Alma mater. University of Freiburg, Germany, University of Essen, Germany. Known for. Inventor of LASIK. Peyman, MD recipient of National Medal of Technology and Innovation, the nation’s highest honor for technological achievement, bestowed by the President of the United States, President Obama, on America's leading innovators . Gholam Peyman is a member of National Academy of Inventors and has, thus far, been granted 1. Our academic structure. The University's academic structure is made up of six schools. Each course is aligned to one of these schools, and if you're a prospective. In September 1939, Nazi Germany invaded Poland, marking the beginning of World War II. As part of Germany’s nonaggression pact with the Soviet Union, eastern Poland. An inventor, a scientist and a brilliant, humanistic practitioner describes Gholam A. Peyman, MD, Ophthalmologist and Retina Surgeon. Through the eyes of his patients. Toute la discographie de Rachid gholam Stay ahead with Sky Sports. Our Transfer Centre has the latest football transfer news, details on done deals, and speculation from the rumour mill. US Patents. His most widely known invention to date is LASIK eye surgery. He was awarded the first US patent for the procedure in 1. In addition to the numerous other honors and awards he has received (please see section 4, for Publications and awards), in 2. Ophthalmology Hall of Fame. At the age of 1. 9, he moved to Germany to begin his medical studies. He received his MD at the University of Freiburg in 1. He completed his internship at St. Johannes Hospital in Diusberg, Germany in 1. Passaic General Hospital in Passaic, New Jersey in 1. Peyman completed his residency in ophthalmology and a retina fellowship at the University of Essen, Essen Germany, in 1. Jules Stein Eye Institute, UCLA School of Medicine in Los Angeles in 1. Peyman held the position of Assistant Professor of Ophthalmology at the UCLA School of Medicine from 1. Associate Professor and then Professor of Ophthalmology at the Illinois Eye and Ear Infirmary, University of Illinois at Chicago during 1. Peyman held a joint appointment at the School of Medicine and also at the Neuroscience Center of Excellence at the Louisiana State University Medical University Medical Center in New Orleans during 1. During 1. 99. 8- 2. Peyman held the Prince Abdul Aziz Bin Ahmed Bin Abdul Aziz Al Saud Chair in Retinal Diseases. During 2. 00. 0- 2. Peyman served as Professor of Ophthalmology and Co- Director, Vitreo- Retinal Service, Tulane University School of Medicine in New Orleans. During 2. 00. 6- 2. Professor of Ophthalmology at the University of Arizona, Tucson with a cross appointment at University of Arizona College of Optical Sciences. He has been emeritus Professor of Ophthalmology at Tulane University since 2. Peyman is currently Professor of Basic Medical Sciences at the University of Arizona College of Medicine - Phoenix & Optical engineering at the University of Arizona in Tucson Peyman was awarded in 2. Doctorate degree from the National University of Cordoba in Argentina. Peyman, because of his interest in the effects of lasers on tissues in the eye began evaluating the potential use of a CO2 laser to modify corneal refraction in rabbits. No prior study had existed on this concept. The laser was applied to the surface of the cornea using different patterns. This laser created significant scarring. His conclusions at that time were: 1) one has to wait for the development of an ablative laser and 2) one should not ablate the surface of the cornea but, instead, the ablation should take place under a flap in order to prevent scarring, pain and other undesirable sequelae. Peyman published the first article on this subject in 1. This was very exciting information, but, unfortunately, Peyman did not have access to this laser, which at the time was new and very expensive By 1. However, because of his previous experience with the CO2 laser, Peyman wanted to avoid surface ablation in order to prevent potential corneal scarring and the pain associated with the removal of the corneal epithelium, necessary to expose the surface of the cornea. Therefore, in July 1. This US patent was accepted after two revisions and issued in June, 1. Peyman performed a number of experimental studies evaluating the effect of various excimer lasers in collaboration with Physics Department of the University of Helsinki, Finland. Since he had purchased an Erb- Yag laser in the U. S., he evaluated the concept using this laser in vivo in rabbit and primate eyes and described the creation of a hinged corneal flap to enable the ablation to be performed on the exposed corneal bed, thus reducing the potential for postoperative scarring and pain. In order to improve the risk/benefit considerations of the LASIK procedure, he invented and patented a broad range of ablative and non- ablative inlays to be placed under the surgically created corneal flap. These inlays offered many potential advantages over the standard LASIK technique, the most significant of which is that the inlay procedure is reversible. For example, the implant has been limited to a size of 2 mm diameter and there is also a possibility that a cornea rejects the implant. In 2. 01. 5 Peyman invented a new refractive surgical procedure that eliminates most of the shortcoming of refractive surgery and implants rejection. His new procedure is now called “Mesik” (Meso, Inside, Implant, Keratomileusis), in which at first a corneal pocket is created with a femtosecond laser, and then the wall of the pocket is crosslinked using riboflavin solution and UV radiation creating a transparent cell- free crosslinked collagen barrier surrounding the implant. This creates an immune privileged cell free space that does not initiate an immune response to an implant. A synthetic organic or polymeric lens can be implanted in the corneal pocket to compensate for the patient’s refractive error. The implant can be exchanged as the eye grows or refractive need dictates. A partial list of Peyman's most significant discoveries and inventions (with first publication date), many of which are still in use today, includes: Modifications and improvements to the operating microscope (1. Method for detecting glaucoma. Development of the Field of Intraocular drug delivery. In the early 1. 97. Peyman investigated the blood ocular barrier, using Peroxidase as a tracer material, to image the site of the barrier in retina which prevented free diffusion of medication from blood in the eye. Because, at that time, despite the systemic antibiotics many eyes were lost after surgery or trauma due to infection, he initiated the evaluation of direct intra- ocular drug delivery. This method has now become an alternative route of drug administration to the systemic and topical medication that in majority of the cases do not cure the infection. Further investigations lead to the prophylactic or therapeutic intraocular administration of the non- toxic doses of numerous medications in the treatment of inflammatory and non- inflammatory diseases of retina in millions of patients. Presently, intraocular drug delivery is accepted and is performed routinely in the treatment of the wet form of age- related macular degeneration and genetic and degenerative diseases of the retina. Intravitreal antineoplastic (cancer) - Toxicity of antineoplastic drugs in vitrectomy infusion fluids (1. Durability of novel implant designs (2. The artificial silicon retina microchip for the treatment of vision loss from retinitis pigmentosa (2. Testing intravitreal toxicity of Bevacizumab (Avastin), (2. Oscillatory photodynamic therapy for choroidal neovascularization and central serous retinopathy; a pilot study (2. Durability of novel implant designs (2. The artificial silicon retina microchip for the treatment of vision loss from retinitis pigmentosa (2. Quantum dots and Optogenetic for artificial retinal and brain stimulation and gene therapy. Methods to regulate polarization of excitable cells. Methods to regulate polarization of excitable cells. Methods to regulate polarization and enhance function of excitable cells. Methods to regulate polarization and enhance function of excitable cells. Adaptic optic phoropter for automated vision correction. External lens adapted to change refractive properties. External lens with flexible membranes for automatic correction of the refractive errors of a person. Adjustable fluidic telescope combined with an intraocular lens. Honors and awards. Public Health Service grant EY0. National Eye Institute the National Institutes of Health Services, Bethesda, MD1. Senior Honor Award, American Academy of Ophthalmology. Honorary member, All India Ophthalmological Laser Society. Included in first edition of The Best Doctors in America: Southeast Region. Honor Award, Vitreous Society. Included in fourth edition of The Best Doctors in America. Gertrude Pyron Lecturer Award, Vitreous Society Annual Mee. ASCRS Innovators Award. Life. me Achievement Award, Iranian Ophthalmology Society. Paul Henkind Lecturer, Macula Society. Hall of Fame of Ophthalmology . Thomas, pp 2. 58- 2. In Mc. Pherson A (ed): New and Controversial Aspects of Vitreoretinal Surgery. Louis, CV Mosby, pp 1. Am J Ophthalmol 8. Ophthalmic Surg 7: 9. Can J Ophthalmol 1. Arch Ophthalmol 1. Retina 8: 2. 88, 1. Can J Ophthalmol 2. Ophthalmic Surg Lasers 2. Am J Ophthalmol 1. Am J Ophthalmol 1. Am J Ophthalmol 1. Arch Ophthalmol 9. Arch Ophthalmol 9. Arch Ophthalmol 9. Int Ophthalmol 9: 4. Arch Ophthalmol 1. Retna 4: 1. 29- 1. Can J Ophthalmol 2. Retna 7: 3. 2- 3. Ophthalmic Surg 1. Arch Ophthalmol 1. Arch Ophthalmol 9. Int Ophthalmol 1. Can J Ophthalmol 2. Ophthalmic Surg 2. Surv Ophthalmol 3. Peyman GA, Retina. Invest Ophthalmol 1. Arch Ophthalmol 9. Invest Ophthalmol 1. Int Ophthalmol. 1. Apr; 9(1): 2. 9- 3. Ann Ophthalmol 9: 4. Ophthalmology 9. 0: 8. Int Ophthalmol 1. Many peer- reviewed publications, including: Am J Ophthalmol 7. Arch Ophthalmol 9. Ophthalmic Surg 5: 3. Am J Ophthalmol 8. Trans- scleral tactile tonometry: ^Ophthalmic Surg 1. Ophthalmic Surg 1. Ophthalmic Surg 1. Ophthalmic Surg 1. Ophthalmic Surg 1. Ophthalmic Surg 1. Surv Ophthalmol 2. Int Ophthalmol 8: 1. Rena 9: 2. 32- 2. Ophthalmic Surg 1. Arch Ophthalmol 1. Arch Ophthalmol 1. Arch Ophthalmol 1. Retna 7: 8. 0- 8. Int Ophthalmol 1. Retina 1. 2: 2. 61- 2. Ophthalmic Surg 1. Int Ophthalmol 1.
0 Comments
Leave a Reply. |
Details
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |